Acumen Pharmaceuticals, Inc. (ABOS)
NASDAQ: ABOS · Real-Time Price · USD
1.980
-0.010 (-0.50%)
Jan 23, 2026, 4:00 PM EST - Market closed
Acumen Pharmaceuticals Market Cap
Acumen Pharmaceuticals has a market cap or net worth of $119.94 million as of January 23, 2026. Its market cap has increased by 9.09% in one year.
Market Cap
119.94M
Enterprise Value
14.72M
1-Year Change
9.09%
Ranking
Category
Stock Price
$1.98
Market Cap Chart
Since the IPO on July 1, 2021, Acumen Pharmaceuticals's market cap has decreased from $618.43M to $119.94M, a decrease of -80.61%. That is a compound annual growth rate of -30.17%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 23, 2026 | 119.94M | -6.16% |
| Dec 31, 2025 | 127.81M | 23.68% |
| Dec 31, 2024 | 103.34M | -53.53% |
| Dec 29, 2023 | 222.38M | 0.62% |
| Dec 30, 2022 | 221.00M | -19.22% |
| Dec 31, 2021 | 273.58M | -55.76% |
| Jul 1, 2021 | 618.43M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Whitehawk Therapeutics | 127.25M |
| Genelux | 127.10M |
| Cognition Therapeutics | 126.23M |
| Actuate Therapeutics | 123.42M |
| Karyopharm Therapeutics | 120.66M |
| Verrica Pharmaceuticals | 118.64M |
| Adagene | 117.36M |
| Artiva Biotherapeutics | 117.32M |